3,621 Shares in Kewaunee Scientific Co. (NASDAQ:KEQU) Bought by Barclays PLC

Barclays PLC acquired a new stake in shares of Kewaunee Scientific Co. (NASDAQ:KEQUFree Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 3,621 shares of the technology company’s stock, valued at approximately $121,000. Barclays PLC owned about 0.13% of Kewaunee Scientific as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. De Lisle Partners LLP grew its stake in shares of Kewaunee Scientific by 36.6% during the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after purchasing an additional 11,511 shares during the period. Renaissance Technologies LLC boosted its holdings in shares of Kewaunee Scientific by 13.4% in the second quarter. Renaissance Technologies LLC now owns 89,611 shares of the technology company’s stock worth $4,230,000 after buying an additional 10,580 shares during the last quarter. State Street Corp bought a new stake in Kewaunee Scientific during the third quarter valued at approximately $266,000. Dimensional Fund Advisors LP increased its holdings in Kewaunee Scientific by 3.6% during the second quarter. Dimensional Fund Advisors LP now owns 177,548 shares of the technology company’s stock valued at $8,378,000 after buying an additional 6,132 shares during the last quarter. Finally, Ritholtz Wealth Management raised its position in Kewaunee Scientific by 24.6% in the third quarter. Ritholtz Wealth Management now owns 10,913 shares of the technology company’s stock worth $363,000 after acquiring an additional 2,156 shares during the period. Institutional investors own 32.69% of the company’s stock.

Insider Transactions at Kewaunee Scientific

In related news, CEO Thomas David Hull III sold 2,000 shares of the business’s stock in a transaction that occurred on Thursday, December 26th. The stock was sold at an average price of $63.01, for a total value of $126,020.00. Following the transaction, the chief executive officer now directly owns 42,497 shares of the company’s stock, valued at approximately $2,677,735.97. The trade was a 4.49 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Donald T. Gardner III sold 1,257 shares of the stock in a transaction that occurred on Friday, January 10th. The shares were sold at an average price of $59.26, for a total transaction of $74,489.82. Following the sale, the chief financial officer now directly owns 21,358 shares of the company’s stock, valued at approximately $1,265,675.08. This trade represents a 5.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 11,994 shares of company stock valued at $729,430 over the last three months. Corporate insiders own 14.20% of the company’s stock.

Kewaunee Scientific Stock Performance

Shares of KEQU opened at $60.97 on Friday. The business has a 50-day simple moving average of $52.03 and a two-hundred day simple moving average of $45.82. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. Kewaunee Scientific Co. has a 52 week low of $27.00 and a 52 week high of $67.20. The stock has a market cap of $175.11 million, a price-to-earnings ratio of 9.66 and a beta of 0.72.

Kewaunee Scientific (NASDAQ:KEQUGet Free Report) last released its earnings results on Wednesday, December 11th. The technology company reported $1.41 earnings per share (EPS) for the quarter. Kewaunee Scientific had a net margin of 9.39% and a return on equity of 25.83%.

Wall Street Analyst Weigh In

Separately, StockNews.com raised shares of Kewaunee Scientific from a “hold” rating to a “buy” rating in a research report on Wednesday, December 18th.

Read Our Latest Research Report on Kewaunee Scientific

Kewaunee Scientific Company Profile

(Free Report)

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Further Reading

Want to see what other hedge funds are holding KEQU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kewaunee Scientific Co. (NASDAQ:KEQUFree Report).

Institutional Ownership by Quarter for Kewaunee Scientific (NASDAQ:KEQU)

Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.